MCRB - Seres Therapeutics Inc
9.32
0.190 2.039%
Share volume: 60,322
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$9.13
0.19
0.02%
Summary score
25%
Profitability
0%
Dept financing
40%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.8%
Return on assets
-8.6%
Return on sales
0%
Return on invested capital
-93.4%
Total debt ratio
54.61%
Debt ratio change over timeo
0%
Current Ratio
6.7%
Quick Ratio
0%
Cash Position Ratio
1.62%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.47%
Return on assets
-9.14%
Return on sales
0%
Return on invested capital
-108.58%
Total debt ratio
56.21%
Debt ratio change over timeo
0%
Current Ratio
6.74%
Quick Ratio
0%
Cash Position Ratio
1.59%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-8.11%
Return on assets
-3.45%
Return on sales
0%
Return on invested capital
-84.52%
Total debt ratio
59.64%
Debt ratio change over time
0%
Current Ratio
6.53%
Quick Ratio
0%
Cash Position Ratio
1.7%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MCRB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -18.8% | 4.12% | 5.6% | 28.84% |
| Return on assets | -8.6% | 2.87% | 3.58% | 3.88% |
| Return on sales | 0% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | -93.4% | 4.34% | 6.5% | 4.27% |
| Profitability | 0% | 52% | 72% | 91% |
| Total debt ratio | 54.61% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 40% | 17% | 14% | 25% |
| Current Ratio | 6.74% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 1.59% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 25% | 43% | 37% |
| Short-term ratios | MCRB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -20.47% | 3.9% | 5.53% | 29.97% |
| Return on assets | -9.14% | 2.93% | 3.51% | 3.83% |
| Return on sales | 0% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | -108.58% | 4.21% | 6.14% | 4.25% |
| Profitability | 0% | 53% | 71% | 92% |
| Total debt ratio | 56.21% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 40% | 18% | 14% | 25% |
| Current Ratio | 6.74% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 1.59% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 25% | 42% | 37% |